Floatz logo

Amitriptyline

Lumbosacral Radiculopathy

Federico II UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the Lumbosacral Radiculopathy cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
University of Miami
Phase 4BBB
LIDOCAINE
C.L.A.Vleggeert-Lankamp
Phase 4BBB
NEPENTHE
Akdeniz University
Phase 4BB
Naproxen
Ostfold Hospital Trust
Phase 4BB
PREDNISONE TABLETS
Kaiser Permanente
Phase 3BB

View all 45 →

Same molecule, other indications

Amitriptyline is also rated in:

Depressive Disorder, MajorDormant
BBB
Indicative ·
77 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
73 / 100
View asset →
EsketamineDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →